A multicenter, randomized controlled study on the efficacy of agomelatine in ameliorating anhedonia, reduced motivation, and circadian rhythm disruptions in patients with major depressive disorder (MDD)

A multicenter, randomized controlled study on the efficacy of agomelatine in ameliorating anhedonia, reduced motivation, and circadian rhythm disruptions in patients with major depressive disorder (MDD)

Abstract Objective To evaluate the clinical efficacy and safety of Agomelatine in improving symptoms in patients with major depressive disorder (MDD), providing more scientific evidence for the treatment of depression, and offering more effective therapeutic options for patients. Methods A total of...

Full description

Bibliographic Details
Main Authors: Ping Guo, Yong Xu, Liang Lv, Min Feng, Yu Fang, Wei-Quan Huang, Shan-Fei Cheng, Min-Cai Qian, Shengliang Yang, Shi-Kai Wang, Huan-Xin Chen
Format: Article
Language:English
Published: BMC 2023-11-01
Series:Annals of General Psychiatry
Subjects:
Major depressive disorder (MDD)
Anhedonia
Hypodynamia
Circadian rhythm
Agomelatine
Selective serotonin reuptake inhibitor (SSRI)
Online Access:https://doi.org/10.1186/s12991-023-00473-y

Internet

https://doi.org/10.1186/s12991-023-00473-y

Similar Items